Intellia Therapeutics, Inc. (0JBU.L) LSE
14.82
+1.889(+14.61%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
14.82
+1.889(+14.61%)
Currency In USD
| Market Cap | 986.22M |
| Enterprise Value | 990.94M |
| P/E Ratio | -4.43 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 25.04 |
| Price/Book Ratio | 2.81 |
| Enterprise/Revenue | 24.22 |
| Enterprise/EBITDA | -4.03 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -5.97 |
| Operating Margin | -6.37 |
| Return On Assets | -0.52 |
| Return On Equity | -0.57 |
| Revenue | 67.67M |
| Revenue/Share | 0.56 |
| Gross Profit | 51.75M |
| EBITDA | -425.07M |
| Net Income | -412.69M |
| Diluted EPS | -3.81 |
| Total Cash | 375.99M |
| Total Cash/Share | 3.17 |
| Total Debt | 80.49M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 6.1 |
| Book Value Per Share | 5.24 |
| 52-Week Change | 95.77 |
| 52-Week High | 46.91 |
| 52-Week Low | 12.9 |
| Moving Average 50 Days | 27.81 |
| Moving Average 200 Days | 33.27 |
| Average Volume | 3,135 |
| Shares Outstanding | 112.21M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |